Biopharma, Healthcare Services, Healthcare
London[email protected] | 44 20 3465 1203 | v-Card
Alan Selby is a Managing Director in Stifel’s Global Healthcare Group, particularly in the area of Biopharma, Biopharma Services, and Consumer Health. He joined Stifel in 2023 through the Torreya acquisition.
Before joining Torreya’s team in 2011, Alan was an Investment Manager at LGV, a UK-based middle-market private equity fund, focusing on healthcare investments. Alan also served as an advisor to the healthcare team at Booz & Company and at Macquarie Group from 2006 to 2009 where he worked on deals in healthcare, infrastructure, and structured finance.
Prior to his career in Finance, Alan was a practicing doctor in teaching hospitals in London specializing in neurology, infectious diseases, endocrinology, and elderly care. Alan holds both an M.Sc. in finance from INSEAD and an M.B.Ch.B. with Hons, University of Liverpool, UK.